SCHEMBL29440623

SCHEMBL29440623

NC(C(=O)O)c1cccc(F)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
HSD17B10 Q99714 3/20 0.50
MEN1 O00255 2/20 0.50
CYP2C9 P11712 2/20 0.50
KMT2A Q03164 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
GRM8 O00222 1/20 0.50
GRM6 O15303 1/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A4 P31645 1/20 0.50
DRD3 P35462 1/20 0.50
GRM4 Q14833 1/20 0.50
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
SLC1A1 P43005 2/20 0.49
EPHX1 P07099 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2597751 1.00 HDAC4 (0.51) HDAC4HDAC7HDAC5HSD17B10MEN1
SCHEMBL431704 1.00 HDAC4 (0.51) HDAC4HDAC7HDAC5HSD17B10MEN1
SCHEMBL23904583 1.00 HDAC4 (0.51) HDAC4HDAC7HDAC5HSD17B10MEN1
SCHEMBL1354525 0.85 HDAC4 (0.51) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL1354521 0.85 HDAC4 (0.51) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL2311787 0.81 SLC1A1 (0.54) HDAC4HDAC7HDAC5CYP2D6CES2
SCHEMBL19696914 0.81 SLC1A1 (0.54) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL30057785 0.81 FFAR1 (0.52) HSD17B10MEN1CYP2C9KMT2ATDP1
SCHEMBL19415782 0.81 HSD17B10 (0.50) HSD17B10MEN1CYP2C9KMT2ATDP1
SCHEMBL3711116 0.80 SRC (0.58) HDAC4HDAC7HDAC5CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114206342-B Allosteric EGFR inhibitors and methods of use thereof 达纳-法伯癌症研究所股份有限公司 2024-10-22 CN disclosed
EP-3986407-A1 ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF Dana-Farber Cancer Institute, Inc. (US) 2022-04-27 EP disclosed
CN-114206342-A Allosteric EGFR inhibitors and methods of use thereof 达纳-法伯癌症研究所股份有限公司 2022-03-18 CN disclosed